GLOW Blend

GLOW Blend is a research peptide formulation combining three compounds — GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), BPC-157 (Body Protection Compound 157), and TB-500 (a thymosin beta-4-derived peptide) — each with its own independent research record. No published studies have examined the combination itself; the evidence base covers each component separately.

The published literature for the individual components is predominantly preclinical, drawn from animal models and in vitro systems. A small number of human studies exist for GHK-Cu in skin applications and for BPC-157 in observational contexts, but no randomised controlled trials have been published for any component.